神経刺激：各種技術と世界市場

世界の神経刺激デバイスの市場規模は、2022年の77億米ドル、2023年の82億米ドルから、予測期間中は7.4%のCAGRで推移し、2028年には117億米ドルの規模に成長すると予測されています。

脊髄刺激デバイスの部門は、2023年の26億米ドルから、予測期間中は4.2％のCAGRで推移し、2028年には32億米ドルの規模に成長すると予測されています。

また、舌下神経刺激装デバイスの部門は、2023年の3億3,550万米ドルから、予測期間中は15.6％のCAGRで推移し、2028年には6億9,210万米ドルの規模に成長すると予測されています。

当レポートでは、世界の神経刺激技術の市場を調査し、市場および技術の概要、市場影響因子の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、技術開発の動向、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 市場および技術の背景

• 神経刺激の概要
• 神経刺激技術の種類
• 脊髄刺激
• 脳深部刺激
• 仙骨神経刺激 (SNS)
• 迷走神経刺激
• 舌下神経刺激
• 経皮的電気神経刺激
• 経頭蓋磁気刺激 (TMS)
• その他の神経刺激技術
• 神経刺激の治療用途
• 慢性疼痛管理
• 神経障害
• 尿失禁・便失禁
• 閉塞性睡眠時無呼吸
• 慢性片頭痛・頭痛
• 心血管疾患
• 胃腸障害
• 肥満
• 精神障害
• 技術開発
• MRIとの互換性
• 充電式デバイスと非充電式デバイス

第4章 市場力学

• 市場動向
• 市場促進要因
• 市場抑制要因

第5章 市場内訳：技術/デバイスタイプ別

• 世界の神経刺激デバイス市場：タイプ別
• 脊髄刺激 (SCS) デバイス
• 経皮的電気神経刺激 (TENS) デバイス
• 脳深部刺激 (DBS) デバイス
• 仙骨神経刺激 (SNS) デバイス
• 迷走神経刺激 (VNS) デバイス
• 舌下神経刺激 (HGNS) デバイス
• 市場規模・予測
• 経頭蓋磁気刺激 (TMS) デバイス
• 他のタイプの神経刺激デバイス

第6章 市場内訳：治療用途別

• 世界の神経刺激デバイス市場：治療用途別
• 慢性疼痛
• 尿失禁・便失禁
• パーキンソン病
• てんかん
• 閉塞性睡眠時無呼吸症候群 (OSA)
• 本態性振戦
• 大うつ病性障害 (MDD) /臨床的うつ病
• 強迫性障害 (OCD)
• その他

第7章 市場内訳：地域別

• 世界の神経刺激デバイス市場：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域

第8章 規制構造

• 規制の枠組み
• 米国
• EU
• 日本

第9章 市場の主要製品・技術

• 近年の治療法の改良・新しい適応症
• 脊髄刺激
• 脳深部刺激
• 仙骨神経刺激 (SNS)
• Axonics
• Medtronic
• 迷走神経刺激
• 舌下神経刺激
• 経皮的電気神経刺激
• 経頭蓋磁気刺激
• 他のタイプの刺激
• 新しい適応症と神経刺激療法

第10章 新たな技術と開発

• 新たな技術と開発
• 閉ループ神経刺激
• 非侵襲的脳刺激技術
• 高周波刺激
• 磁気共鳴誘導集束超音波
• 光遺伝学
• 生体電子医学
• 無線および遠隔制御デバイス

第11章 最近のM&A

第12章 競合情勢

• 製品部門別の企業シェア
• 脊髄刺激デバイス
• 脳深部刺激デバイス
• 仙骨神経刺激デバイス
• 迷走神経刺激デバイス
• 舌下神経刺激デバイス
• 経頭蓋磁気刺激デバイス
• 経皮的電気神経刺激デバイス
• 最近の業界活動

第13章 企業プロファイル

• ABBOTT LABORATORIES
• ALEVA NEUROTHERAPEUTICS SA
• AVERY BIOMEDICAL DEVICES INC.
• AXONICS INC.
• BIOINDUCTION LTD.
• BIOVENTUS LLC
• BIOWAVE CORP.
• BOSTON SCIENTIFIC CORP.
• BRAINSWAY LTD.
• COCHLEAR AMERICAS
• CVRX INC.
• ELECTROCORE INC.
• INSPIRE MEDICAL SYSTEMS INC.
• INTEGER HOLDINGS CORP.
• LABORIE INC.
• LIVANOVA PLC
• MAG & MORE GMBH
• MAGSTIM INC.
• MEDTRONIC PLC
• NALU MEDICAL INC.
• NEUROMED CONSULTING INC.
• NEUROMETRIX INC.
• NEURONETICS INC.
• NEUROPACE INC.
• NEUROSIGMA INC.
• NEUROVALENS LTD.
• NEVRO CORP.
• NEXSTIM PLC
• NYXOAH SA
• SOTERIX MEDICAL INC.
• SYNAPSE BIOMEDICAL INC.
• XAVANT TECHNOLOGY (PTY) LTD.
• ZOLL MEDICAL CORP.

第14章 付録：頭字語

List of Tables

• Summary Table : Global Market for Neurostimulation Devices, by Type, Through 2028
• Table 1 : Prevalence of Chronic Pain and High-Impact Chronic Pain Among U.S. Adults, by Sociodemographic Characteristics, 2016
• Table 2 : Type of Chronic Pain, U.S
• Table 3 : Prevalence of Adult Overweight and Obese Population, by Country, 2014-2022
• Table 4 : Global Market for Neurostimulation Devices, by Type, Through 2028
• Table 5 : Global Market for SCS Devices, by Region, Through 2028
• Table 6 : Global Market for TENS Devices, by Region, Through 2028
• Table 7 : Global Market for DBS Devices, by Region, Through 2028
• Table 8 : Global Market for SNS Devices, by Region, Through 2028
• Table 9 : Global Market for VNS Devices, by Region, Through 2028
• Table 10 : Global Market for HGNS Devices, by Region, Through 2028
• Table 11 : Global Market for TMS Devices, by Region, Through 2028
• Table 12 : Global Market for Other Types of Neurostimulation Devices, by Region, Through 2028
• Table 13 : Global Market for Neurostimulation Devices, by Therapeutic Application, Through 2028
• Table 14 : Global Market for Neurostimulation Devices, by Region, Through 2028
• Table 15 : Regulatory Approval: U.S. vs. Europe
• Table 16 : Implantable Neurostimulation Devices Approved, January 2018-May 2023
• Table 17 : Currently Available Spinal Cord Stimulation Systems
• Table 18 : Currently Available Deep Brain Stimulation Systems
• Table 19 : Currently Available Sacral Nerve Stimulation Systems
• Table 20 : Currently Available Vagus Nerve Stimulation Systems
• Table 21 : FDA-Approved TENS Systems for Pain Relief Treatment, 2015-2021
• Table 22 : FDA-Approved TENS Systems for Treatment of Migraine Pain Relief, 2015-2021
• Table 23 : Currently Available Phrenic Nerve Stimulation Systems for Respiratory Insufficiency
• Table 24 : Currently Available HGNS Systems for Respiratory Insufficiency
• Table 25 : Currently Available Peripheral Nerve Stimulation Systems
• Table 26 : Currently Available Transcranial Magnetic Stimulating Systems
• Table 27 : Currently Available Gastric Electrical Stimulation Systems
• Table 28 : Neurostimulation Stimulation Product Pipeline
• Table 29 : Active Clinical Trials on Spinal Cord Stimulation Technology
• Table 30 : Active Clinical Trials on DBS Technology
• Table 31 : Active Clinical Trials on VNS Technology
• Table 32 : Active Clinical Trials on Sacral Nerve Stimulation Technology
• Table 33 : Active Clinical Trials on Peripheral Nerve Stimulation Technology
• Table 34 : Active Clinical Trials on Hypoglossal Nerve Stimulation Technology
• Table 35 : Shares of Companies in the Global Market for SCS Devices, 2022
• Table 36 : Shares of Companies in the Market for DBS Devices, 2022
• Table 37 : Aleva Neurotherapeutics SA: News
• Table 38 : Axonics Inc.: Annual Revenue, 2022
• Table 39 : Axonics Inc.: News
• Table 40 : Axonics Inc.: Product Portfolio
• Table 41 : Bioventus LLC: Annual Revenue, 2022
• Table 42 : Bioventus LLC: News
• Table 43 : Bioventus LLC: Product Portfolio
• Table 44 : Boston Scientific Corp.: Annual Revenue, 2022
• Table 45 : Boston Scientific Corp.: News
• Table 46 : Boston Scientific Corp.: Product Portfolio
• Table 47 : Medtronic PLC: Annual Revenue, 2022
• Table 48 : Synapse Biomedical Inc.: News
• Table 49 : Xavant Technology: Product Portfolio
• Table 50 : Acronyms Used in This Report

List of Figures

• Summary Figure : Global Market for Neurostimulation Devices, by Type, 2020-2028
• Figure 1 : Global Market Shares of Neurostimulation Devices, by Type, 2022
• Figure 2 : Global Market for SCS Devices, by Region, 2020-2028
• Figure 3 : Global Market for TENS Devices, by Region, 2020-2028
• Figure 4 : Global Market for DBS Devices, by Region, 2020-2028
• Figure 5 : Global Market for SNS Devices, by Region, 2020-2028
• Figure 6 : Global Market for VNS Devices, by Region, 2020-2028
• Figure 7 : Global Market for HGNS Devices, by Region, 2020-2028
• Figure 8 : Global Market for TMS Devices, by Region, 2020-2028
• Figure 9 : Global Market for Other Types of Neurostimulation Devices, by Region, 2020-2028
• Figure 10 : Global Market Shares of Neurostimulation Devices, by Therapeutic Application, 2022
• Figure 11 : Global Market Shares of Neurostimulation Devices, by Region, 2022
• Figure 12 : Shares of Leading Companies in the Global Market for SCS Devices, 2022
• Figure 13 : Shares of Companies in the Market for DBS Devices, 2022
• Figure 14 : Abbott: Diagnostics Revenue, 2020-2022
• Figure 15 : Abbott: Diagnostics Market Share, by Business Segment, 2022
• Figure 16 : Abbott: Revenue Shares, by Business Unit, 2021
• Figure 17 : Abbott: Revenue Shares, by Market, 2021
• Figure 18 : Axonics Inc.: Annual Revenue, 2021 and 2022
• Figure 19 : Axonics Inc.: Revenue Shares, by Business Unit, 2022
• Figure 20 : Axonics Inc.: Revenue Shares, by Country/Region, 2022
• Figure 21 : Bioventus LLC: Annual Revenue, 2021 and 2022
• Figure 22 : Bioventus LLC: Revenue Shares, by Business Unit, 2022
• Figure 23 : Bioventus LLC: Revenue Shares, by Country/Region, 2022
• Figure 24 : Boston Scientific Corp.: Annual Revenue, 2021 and 2022
• Figure 25 : Boston Scientific Corp.: Revenue Shares, by Business Unit, 2022
• Figure 26 : Boston Scientific Corp.: Revenue Shares, by Country/Region, 2022
• Figure 27 : Medtronic PLC: Annual Revenue, 2021 and 2022
• Figure 28 : Medtronic PLC: Revenue Shares, by Business Unit, 2022
• Figure 29 : Medtronic PLC: Revenue Shares, by Country/Region, FY2023

Highlights:

The global neurostimulation devices market should reach $11.7 billion by 2028 from $8.2 billion in 2023 at a compound annual growth rate (CAGR) of 7.4% for the forecast period of 2023 to 2028. Whereas the market was $7.7 billion in 2022 (base year).

Spinal cord stimulation devices segment of the global neurostimulation devices market is expected to grow from $2.6 billion in 2023 to $3.2 billion in 2028 at a CAGR of 4.2% for the forecast period of 2023 to 2028.

Hypoglossal nerve stimulation devices segment of the global neurostimulation devices market is expected to grow from $335.5 million in 2023 to $692.1 million in 2028 at a CAGR of 15.6% for the forecast period of 2023 to 2028.

Report Scope:

This report provides a comprehensive study of the global market for neurostimulation technologies and devices. It provides a detailed description of the different types of neurostimulation technologies and devices (invasive and noninvasive) and their current and historical market revenues.

Neurostimulation technologies and devices include spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, hypoglossal nerve stimulation, transcutaneous electrical nerve stimulation, transcranial magnetic stimulation and others.

This report also covers in detail the therapeutic applications of neurostimulation technologies and devices, including chronic pain, Parkinson's disease, epilepsy, urinary and fecal incontinence, obstructive sleep apnea, essential tremor, obsessive compulsive disorder, major depressive disorder/clinical depression and others. An in-depth analysis of the global market for neurostimulation technologies and devices includes historical data and market projections by device type, therapeutic application and region.

Report Includes:

• 51 tables
• An overview of the global markets and technologies for neurostimulation
• Estimation of the market size and analyses of market trends, with data from 2020 to 2022, estimates for 2023 and projection of CAGR through 2028
• Description of Dorsal Root Ganglion (DRG) neurostimulator system and discussion on approved indications of stimulation therapy for various diseases
• Detailed description of various types of stimulation such as spinal cord stimulation, transcutaneous electrical nerve stimulation, deep brain stimulation, sacral nerve stimulation, Vagus nerve stimulation, hypoglossal nerve stimulation, and transcranial magnetic stimulation; and discussion on their mode of action and advantages
• Information on recent therapy improvements and new indications for use, and discussion on alternatives to traditional stimulation therapies
• Coverage of ongoing scientific discoveries and technological advances in neurostimulation technologies and insights into marketed and pipeline (R&D) products, product recalls and reimbursement policies
• Market share analysis of neurostimulation devices by application, type and region, and evaluation of market size and forecast, and detailed analysis of drivers, challenges and opportunities affecting market growth
• Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
• Comprehensive company profiles of major players of the industry, including Axonics Inc., Boston Scientific Corp., Medtronic PLC, Synapse Biomedical Inc. and Xavant Technology

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing the Study
• What's New in This Update?
• Scope of Report
• Methodology and Information Sources
• Regional Breakdown

Chapter 2 Summary and Highlights

• Market Outlook

Chapter 3 Market and Technology Background

• Overview of Neurostimulation
• Types of Neurostimulation Technologies
• Spinal Cord Stimulation
• Deep Brain Stimulation
• Sacral Nerve Stimulation (SNS)
• Vagus Nerve Stimulation
• Hypoglossal Nerve Stimulation
• Transcutaneous Electrical Nerve Stimulation
• Transcranial Magnetic Stimulation (TMS)
• Other Neurostimulation Technologies
• Therapeutic Applications for Neurostimulation
• Chronic Pain Management
• Neurological Disorders
• Urinary and Fecal Incontinence
• Obstructive Sleep Apnea
• Chronic Migraine and Headache
• Cardiovascular Diseases
• Gastrointestinal Disorders
• Obesity
• Psychiatric Disorders
• Technological Developments
• MRI Compatibility
• Rechargeable and Non-rechargeable Devices

Chapter 4 Market Dynamics

• Market Trends
• Drivers
• Market Restraints

Chapter 5 Market Breakdown by Technology/Device Type

• Global Market for Neurostimulation Devices by Type
• Spinal Cord Stimulation (SCS) Devices
• Transcutaneous Electrical Nerve Stimulation (TENS) Devices
• Deep Brain Stimulation (DBS) Devices
• Sacral Nerve Stimulation (SNS) Devices
• Vagus Nerve Stimulation (VNS) Devices
• Hypoglossal Nerve Stimulation (HGNS) Devices
• Market Size and Forecast
• Transcranial Magnetic Stimulation (TMS) Devices
• Other Types of Neurostimulation Devices

Chapter 6 Market Breakdown by Therapeutic Application

• Global Market for Neurostimulation Devices by Therapeutic Application
• Chronic Pain
• Urinary and Fecal Incontinence
• Parkinson's Disease
• Epilepsy
• Obstructive Sleep Apnea (OSA)
• Essential Tremor
• Major Depressive Disorder (MDD)/Clinical Depression
• Obsessive Compulsive Disorder (OCD)
• Other Therapeutic Applications

Chapter 7 Market Breakdown by Region

• Global Market for Neurostimulation Devices by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 8 Regulatory Structure

• Regulatory Framework
• U.S.
• European Union
• Japan

Chapter 9 Key Products and Technologies on the Market

• Recent Therapeutic Improvements and New Indications
• Spinal Cord Stimulation
• Deep Brain Stimulation
• Sacral Nerve Stimulation (SNS)
• Axonics
• Medtronic
• Vagus Nerve Stimulation
• Hypoglossal Nerve Stimulation
• Transcutaneous Electrical Nerve Stimulation
• Transcranial Magnetic Stimulation
• Other Types of Stimulation
• New Indications and Neurostimulation Therapies

Chapter 10 Emerging Technologies and Developments

• Emerging Technologies and Developments
• Closed-Loop Neurostimulation
• Non-Invasive Brain Stimulation Techniques
• High-Frequency Stimulation
• Magnetic Resonance-guided Focused Ultrasound
• Optogenetics
• Bioelectronic Medicine
• Wireless and Remote-Controlled Devices

Chapter 11 Recent M&A

• M&A in the Neurostimulation Technologies Industry

Chapter 12 Competitive Landscape

• Company Market Shares by Product Segment
• Spinal Cord Stimulation Devices
• Deep Brain Stimulation Devices
• Sacral Nerve Stimulation Devices
• Vagus Nerve Stimulation Devices
• Hypoglossal Nerve Stimulation Devices
• Transcranial Magnetic Stimulation Devices
• Transcutaneous Electrical Nerve Stimulation Devices
• Recent Industry Activities

Chapter 13 Company Profiles

• ABBOTT LABORATORIES
• ALEVA NEUROTHERAPEUTICS SA
• AVERY BIOMEDICAL DEVICES INC.
• AXONICS INC.
• BIOINDUCTION LTD.
• BIOVENTUS LLC
• BIOWAVE CORP.
• BOSTON SCIENTIFIC CORP.
• BRAINSWAY LTD.
• COCHLEAR AMERICAS
• CVRX INC.
• ELECTROCORE INC.
• INSPIRE MEDICAL SYSTEMS INC.
• INTEGER HOLDINGS CORP.
• LABORIE INC.
• LIVANOVA PLC
• MAG & MORE GMBH
• MAGSTIM INC.
• MEDTRONIC PLC
• NALU MEDICAL INC.
• NEUROMED CONSULTING INC.
• NEUROMETRIX INC.
• NEURONETICS INC.
• NEUROPACE INC.
• NEUROSIGMA INC.
• NEUROVALENS LTD.
• NEVRO CORP.
• NEXSTIM PLC
• NYXOAH SA
• SOTERIX MEDICAL INC.
• SYNAPSE BIOMEDICAL INC.
• XAVANT TECHNOLOGY (PTY) LTD.
• ZOLL MEDICAL CORP.

Chapter 14 Appendix: Acronyms